Skip to main content

Logos Global Management LP

Position in AVTX — Avalo Therapeutics, Inc.

CIK 1792126 San Francisco, CA

Position in AVTX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$21,252,000
+$16,773,000 QoQ
Shares Held
1,150,000
+283.3% QoQ
Ownership
2.14%
of shares outstanding
% of Portfolio
0.91%
of 13F equity value
Holder Rank
#21
of 126 holders
Holding Since
Jun 2024
4 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AVTX Over Time

Shares Held

Position Value (USD)

Derivatives in AVTX

reported options exposure · as of Mar 31, 2026
CallValue
$14,930,000
CallShares
1,000,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Logos Global Management LP holds $2,282,084,584 across 63 Biotechnology names. AVTX ranks #33 (0.9% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in AVTX

Export CSV
6 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $21,252,000 1,150,000
2026-03-31 $14,930,000 1,000,000
2026-03-31 $4,479,000 300,000
2026-03-26 $17,925,750 1,285,000
2024-09-30 $5,121,250 539,079
2024-06-30 $6,722,315 539,079